PARIS--ExonHit Therapeutics, the inventor of a gene profiling technology called Differential Analysis of Transcripts Alternatively Spliced, has introduced a predictive toxicology tool to enhance pharmaceutical and agrochemical research and development. Safe-Hit is a nucleic acid array that incorporates a library of genetic signaturesselected for being affected when cells and tissues are subjected to toxic stresses. A software module in the product reads the microarray, interprets results, and ranks compounds by toxicity.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.